Hwail Pharm: 주요사항보고서(유상증자결정)
AI reading
★★★ Bullish · Rights offering
경영전략 목적의 제3자배정 유상증자 및 1년 보호예수
Key figures: 신주 1,379,690주, 발행가 7,248원
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Hwail Pharm
For information only. Not investment advice.